← Eichor
Study identifier: NCT05973097 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy

Condition: Oral Lichen Planus  ·  Sponsor: Peking University Third Hospital

PhaseNA
Planned participants156
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Oral lichen planus (OLP) is a common chronic inflammatory disease of the oral mucosa and is considered a precancerous condition. It is characterized by white reticular changes in the oral mucosa, which can progress to erosions and cause pain in severe cases. The pathogenesis of OLP is still unclear, but it is believed to be a T-lymphocyte-mediated autoimmune disease. Currently, only symptomatic treatments are available, and there is no definitive cure. In this project, we plan to use TCM differentiation to categorize OLP patients and conduct a randomized controlled clinical trial to demonstrate the enhanced therapeutic effect of paeoniflorin combined with photodynamic therapy for OLP. The implementation of this project will provide new insights into the clinical management of OLP, improve our understanding of the treatment mechanisms, and have important theoretical and clinical implications.

This description comes directly from the study's public registry record.

Talk to the study team

Zhihui Zhang, Dr.  ·  010-82266125  ·  wisdomzhangzhihui@163.com

Lin Zeng

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University Third HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05973097